Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$1.13B |
| 2 |
AT&T
T
|
+$275M |
| 3 |
Apple
AAPL
|
+$248M |
| 4 |
Walt Disney
DIS
|
+$235M |
| 5 |
Nike
NKE
|
+$195M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.4B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.17B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$863M |
| 4 |
Advanced Micro Devices
AMD
|
+$808M |
| 5 |
Amazon
AMZN
|
+$783M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 92.82% |
| 2 | Technology | 1.6% |
| 3 | Consumer Discretionary | 1.3% |
| 4 | Financials | 0.99% |
| 5 | Communication Services | 0.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3051
Ingersoll Rand
IR
$30.5B
| $7.6M | ﹤0.01% |
122,897
+38,580
| +46% | +$2.2M |
|
3052
Vanguard Dividend Appreciation ETF
VIG
$113B
| $7.6M | ﹤0.01% |
+44,257
| New | +$7.29M |
|
3053
Beam Therapeutics
BEAM
$3.03B
| $7.59M | ﹤0.01% |
95,256
+31,770
| +50% | +$2.72M |
|
3054
PUT
FirstEnergy
FE
$26.5B
| $7.58M | ﹤0.01% |
182,300
-668,000
| -79% | -$25.8M |
|
3055
CALL
LivaNova
LIVN
$4.43B
| $7.58M | ﹤0.01% |
86,700
+14,500
| +20% | +$1.21M |
|
3056
PUT
Corteva
CTVA
$56B
| $7.57M | ﹤0.01% |
160,200
-125,000
| -44% | -$5.69M |
|
|
P
3057
Everpure Inc
P
$31B
| $7.57M | ﹤0.01% |
232,617
-268,574
| -54% | -$7.79M |
|
|
VMRK
3058
Vivmark Residential
VMRK
$26.1B
| $7.57M | ﹤0.01% |
83,647
-41,700
| -33% | -$3.59M |
|
3059
PUT
Rockwell Automation
ROK
$47.8B
| $7.57M | ﹤0.01% |
21,700
-21,300
| -50% | -$7.05M |
|
3060
CALL
Stride
LRN
$3.61B
| $7.57M | ﹤0.01% |
227,000
-44,800
| -16% | -$1.55M |
|
3061
CALL
Invesco CurrencyShares Euro Currency Trust
FXE
$358M
| $7.56M | ﹤0.01% |
71,500
+12,000
| +20% | +$1.28M |
|
3062
iShares Russell 2000 Growth ETF
IWO
$14.8B
| $7.56M | ﹤0.01% |
25,783
-55,229
| -68% | -$16.6M |
|
3063
PUT
Celldex Therapeutics
CLDX
$3.07B
| $7.55M | ﹤0.01% |
195,500
+6,900
| +4% | +$301K |
|
3064
CALL
Universal Health Services
UHS
$10.1B
| $7.55M | ﹤0.01% |
58,200
-1,400
| -2% | -$180K |
|
3065
CALL
Evergy
EVRG
$18.6B
| $7.54M | ﹤0.01% |
109,900
+71,500
| +186% | +$4.65M |
|
3066
Takeda Pharmaceutical
TAK
$57.6B
| $7.54M | ﹤0.01% |
552,865
-559,943
| -50% | -$7.85M |
|
3067
CALL
Axalta
AXTA
$7.92B
| $7.54M | ﹤0.01% |
227,500
-403,100
| -64% | -$12.8M |
|
|
AZPN
3068
PUT
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $7.52M | ﹤0.01% |
49,400
-13,600
| -22% | -$2.07M |
|
3069
PUT
Vuzix
VUZI
$219M
| $7.52M | ﹤0.01% |
867,000
-133,200
| -13% | -$1.44M |
|
3070
CALL
PBF Energy
PBF
$8.45B
| $7.51M | ﹤0.01% |
579,300
-120,800
| -17% | -$1.67M |
|
3071
VeriSign
VRSN
$26.4B
| $7.5M | ﹤0.01% |
29,529
+6,622
| +29% | +$1.53M |
|
3072
CALL
Check Point Software Technologies
CHKP
$14.1B
| $7.47M | ﹤0.01% |
64,100
-19,200
| -23% | -$2.23M |
|
3073
CALL
UBS Group
UBS
$168B
| $7.46M | ﹤0.01% |
417,400
+92,200
| +28% | +$1.62M |
|
3074
US Commodity Index
USCI
$390M
| $7.46M | ﹤0.01% |
171,581
+47,188
| +38% | +$2.02M |
|
3075
VanEck Rare Earth/Strategic Metals ETF
REMX
$2.27B
| $7.45M | ﹤0.01% |
66,442
+40,502
| +156% | +$4.62M |
|
Similar funds
Jeff Yass's Q4 2021 Portfolio in Review
As of Q4 2021, Jeff Yass held 14,586 positions worth $667B, down 11% from $745B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Jeff Yass's Q4 2021 filing shows 1,953 new, 4,555 increased, 6,197 reduced and 1,571 closed positions. Its largest new stake was iShares Core MSCI Emerging Markets ETF: 1,306,619 shares worth $78.2M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.4B.
By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q4 2021 buy was iShares Core MSCI Emerging Markets ETF: 1,306,619 shares worth $78.2M.
- Jeff Yass added most to Citigroup in Q4 2021, an estimated $1.13B increase.
- Jeff Yass's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.4B.
- Jeff Yass fully exited Stamps.com, Inc. in Q4 2021, selling an estimated $78.8M.
- Jeff Yass's ten largest holdings make up 32% of its $667B portfolio in Q4 2021.
- Jeff Yass opened 1,953 new positions and closed 1,571 in Q4 2021.
- Jeff Yass's portfolio value fell 11% quarter-over-quarter to $667B.
Based on Susquehanna International Group's 13F filing for Q4 2021, filed 14 Feb 2022.